FDA Advisers Endorse Gene Therapy To Treat Form of Blindness (cbsnews.com)
An anonymous reader quotes a report from CBS News: A panel of U.S. health advisers has endorsed an experimental approach to treating inherited blindness, setting the stage for the likely approval of an innovative new genetic medicine. A panel of experts to the Food and Drug Administration voted unanimously in favor of Spark Therapeutics' injectable therapy, which aims to improve vision in patients with a rare mutation that gradually destroys normal vision. The vote amounts to a recommendation to approve the therapy. According to Spark Therapeutics' website, inherited retinal diseases are a group of rare blinding conditions caused by one of more than 220 genes. Some living with these diseases experience a gradual loss of vision, while others may be born without the ability to see or lose their vision in infancy or early childhood. Genetic testing is the only way to verify the exact gene mutation that is the underlying cause of the disease.
Genetic testing only way to find out, well, to make every one safer, every one needs to be genetically tested. A little bit suspect one to go for in the first instance, the health insurance companies will love that test, I wonder how far they will stretch it. The best way for insurance companies to manipulate genetic test pilfering. Wait for you to get health insurance, sneakily grab your genetic test and find you have genetic predispositions, hope you forget to say anything about your genetic test record and provide health care coverage, as you are the best possible person to cover, as soon as you try to make a major claim, whamo. After decades of collecting insurance premiums, they say you have a pre-existing genetic condition that you didn't declare and tell you to fuck off and drop dead, hah hah.
Chaos - everything, everywhere, everywhen
Considering that what this drug is treating isn't a life-threatening condition, the vote to approve this drug shows just how confident regulators are that this form of direct gene modification is likely to prove to be safe in the long-term. Because of this, we can expect a flood of applications for new gene therapies in the next few years.
For people suffering from retina detachment and other retina diseases, current form of eye-surgery is simply insufficient
Patients undergone retinal surgery know that one day they will still go blind, because their retina will still detach / degrade, and no doctor in the world can do anything about it
If this form of genetic treatment can 'repair' the retina (or somehow re-attach the retina back to where it should be) then it would be a life saver to many
Because they should test this on Jerry Layne FIRST!
slashdot: A failed experiment.
There are a number of theories about what would happen if you gave people who were born blind the ability to see. People who are born blind repurpose their visual cortex for things like interpreting braille. Direct stimulation fails to produce visual information, too.
Every time I read "innovative new" I feel the urge to smack someone in the face.
The FDA Advisory Committee materials and presentations are here, for those interested.
Note that this is for a very specific genetic cause of blindness, where a mutation in a gene for an enzyme results in effective loss of that specific enzyme. The drug is a retroviral vector encoding only the missing gene. Other causes of blindness, genetic or otherwise, wouldn't benefit from this treatment.
Pretty amazing, and a long time coming for gene therapy, since Jesse Gelsinger's death prompted a long close look at using adenoviral vectors for gene therapy.
Cost info?
The disease this is intended to treat is Leber's congenital amaurosis (LCA). It's buried in the article. Seems like the kind of important specific technical information that definitely belongs in a Slashdot summary.
I am a geek attorney, but not your geek attorney unless you've already retained me. This is not legal advice.
The drug is not a retrovirus. It uses adeno-associated virus (AAV) as the delivery platform; unlike a retrovirus, AAV does not integrate into the genome. Note also that despite having similar names, AAV and adenoviral vectors are very different.
Examine even your most deeply held beliefs. Nobody is always right.